Literature DB >> 11601138

Cyclin D1 overexpression in multiple myeloma. A morphologic, immunohistochemical, and in situ hybridization study of 71 paraffin-embedded bone marrow biopsy specimens.

E Athanasiou1, V Kaloutsi, V Kotoula, P Hytiroglou, I Kostopoulos, C Zervas, P Kalogiannidis, A Fassas, J I Christakis, C S Papadimitriou.   

Abstract

Cyclin D1 expression was evaluated by immunohistochemical analysis and biotin-labeled in situ hybridization (ISH) in a series of 71 decalcified, paraffin-embedded bone marrow biopsy specimens from patients with multiple myeloma (MM). Cyclin D1 messenger RNA (mRNA) overexpression was detected by ISH in 23 (32%) of 71 cases, whereas cyclin D1 protein was identified by immunohistochemical analysis in 17 (24%) of 71 specimens. All cases that were positive by immunohistochemical analysis also were positive by ISH. Statistically significant associations were found between cyclin D1 overexpression and grade of plasma cell differentiation and between cyclin D1 overexpression and extent of bone marrow infiltration. Our findings demonstrate the following: (1) ISH for cyclin D1 mRNA is a sensitive method for the evaluation of cyclin D1 overexpression in paraffin-embedded bone marrow biopsy specimens with MM. (2) ISH is more sensitive than immunohistochemical analysis in the assessment of cyclin D1 expression. (3) Cyclin D1 overexpression in MM is correlated positively with higher histologic grade and stage.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11601138     DOI: 10.1309/BVT4-YP41-LCV2-5GT0

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  7 in total

Review 1.  Bone marrow immunohistology of plasma cell neoplasms.

Authors:  A Wei; S Juneja
Journal:  J Clin Pathol       Date:  2003-06       Impact factor: 3.411

2.  Dual Targeting of CDK4 and ARK5 Using a Novel Kinase Inhibitor ON123300 Exerts Potent Anticancer Activity against Multiple Myeloma.

Authors:  Deepak Perumal; Pei-Yu Kuo; Violetta V Leshchenko; Zewei Jiang; Sai Krishna Athaluri Divakar; Hearn Jay Cho; Ajai Chari; Joshua Brody; M V Ramana Reddy; Weijia Zhang; E Premkumar Reddy; Sundar Jagannath; Samir Parekh
Journal:  Cancer Res       Date:  2016-02-12       Impact factor: 12.701

3.  Primary plasma cell leukaemia with unusual presentations: a case series.

Authors:  Urmila Majhi; Kanchan Murhekar; Shirley Sundersingh; K R Rajalekshmi
Journal:  Indian J Hematol Blood Transfus       Date:  2014-07-04       Impact factor: 0.900

4.  Plasma Cell Dyscrasias in India-2017 Updates.

Authors:  Arihant Jain; Pankaj Malhotra
Journal:  Indian J Hematol Blood Transfus       Date:  2017-12-13       Impact factor: 0.900

5.  Immunohistochemical analysis of cyclin D1 and p53 in multiple myeloma: relationship to proliferative activity and prognostic significance.

Authors:  O Markovic; D Marisavljevic; V Cemerikic; N Suvajdzic; N Milic; M Colovic
Journal:  Med Oncol       Date:  2004       Impact factor: 3.064

6.  Cyclin D1 expression in multiple myeloma by immunohistochemistry: Case series of 14 patients and literature review.

Authors:  Somanath Padhi; Renu G'boy Varghese; Anita Ramdas
Journal:  Indian J Med Paediatr Oncol       Date:  2013-10

7.  Epigenetic silencing of LPP/miR-28 in multiple myeloma.

Authors:  Zhenhai Li; Kwan Yeung Wong; Godfrey Chi-Fung Chan; Chor Sang Chim
Journal:  J Clin Pathol       Date:  2017-08-03       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.